… granuloma‐like lesions induced by EGFR inhibitors, 34 (97.1%) demonstrated complete
resolution and only one (2.9%) had partial resolution after 12 weeks of topical betaxolol …

… This contraindicates their prescription for patients who suffer from COPD, asthma, … , which
could result in exacerbating glaucomatous progression [9]. Betaxolol was developed with the …

… , and betaxolol, which reduce IOP by 20–25% except betaxolol … Patients with asthma or
chronic obstructive pulmonary … beta-2 receptors, while betaxolol has a lower risk of pulmonary …

… Education of glaucoma patients and caregivers who remind people to take their … study,
glaucoma patients, and if applicable caregivers, received an intervention that included glaucoma …

… either betaxolol, brinzolamide, or latanoprost in the left eye. All … asthmatic symptoms in
patients with no history of asthma and therefore should be administered with caution in patients …

… This class of oral medications should be used cautiously in patients with a history of cardiac
disease and is relatively contraindicated in patients with asthma and chronic obstructive …

… experience various atopic conditions including eczema, asthma, and allergic rhinitis. Atopic
… beyond betaxolol (beta-blocker) and brinzolamide (carbonic anhydrase inhibitor) (Table 4). …

… are contraindicated in patients with asthma, … patients assume is a treatment for glaucoma.
Smoking marijuana has been shown to decrease IOP in individuals with or without glaucoma…

… patients, with surgery offered to those with worsening glaucoma despite medical and/or laser
treatment, or patients … This article aims to provide an overview of glaucoma with a focus on …

… , asthma, vascular disease, cancer and glaucoma. In 2014, Japan approved the ROCK inhibitor
Ripasudil to treat glaucoma and … to discover new anti-glaucoma ROCK inhibitors. In this …